CorMedix Inc (CRMD)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

400 CONNELL DRIVE BERKELEY HEIGHTS, NJ 07922

Data as of 2020-07-04
Market Cap160.682 Million Shares Outstanding26.127 Million Avg 30-day Volume225.836 Thousand
P/E Ratio Dividend Yield EPS-1.77
Price/Sales1014.65 Price cash flow ratio Price free cash flow ratio-10.1
Book Value0.83 Price to Tangible Book7.44 Alpha0.01
Short Interest Ratio15.17 % Short Interest to Float12.2 R-squared0.143481
BETA2.95463 52-week High/Low9.99 / 2.16 Stddev0.332168
View SEC Filings from CRMD instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 60 12 (0.79%)
Aggregate 13F shares on 03/31/2020: 6.614 Million 3.153 Million
Aggregate 13F shares on 12/31/2019: 6.439 Million 2.74 Million
Percent change: 2.72% 15.05%
Funds creating new positions: 6 3
Funds Adding to an existing position: 21 5
Funds closing out their position: 8 3
Funds reducing their position: 12 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CRMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

10 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TELLEZ CORA M

  • Director
72,072 2020-06-30 0

DUNTON ALAN W

578,935 2020-06-16 2

DILLIONE JANET

53,473 2020-05-15 6

KAPLAN MYRON

119,734 2020-05-15 4

ELLISON RUSSELL H SEE REMARKS

  • Officer
  • Director
12,050 2020-05-14 0

ARMSTRONG JR. JOHN L. EXEC VP OF TECH OPERATIONS

69,378 2020-05-11 2

MASSON-HURLBURT ELIZABETH EVP, HEAD OF CLINICAL OPS.

8,000 2020-05-11 2

MOUNTS PHOEBE GENERAL COUNSEL

4,675 2020-05-11 4

DAVID MATTHEW T EVP, CHIEF FINANCIAL OFFICER

0 2020-05-11 2

BALUCH KHOSO CHIEF EXECUTIVE OFFICER

56,075 2020-03-18 3

LENZ BRIAN EVP, CFO

  • Officer
72,142 2020-02-28 0

KHAN MEHMOOD

133,017 2020-02-25 2

LEFKOWITZ STEVEN W

91,928 2020-01-07 2

ABRAMS JUDITH R CHIEF MEDICAL OFFICER

  • Officer
25,000 2019-10-28 0

COOK ROBERT W. CHIEF FINANCIAL OFFICER

27,517 2019-09-30 3

BASTANI BAMI

  • Director
22,017 2019-06-19 0

GELBFISH GARY A.

2,668,871 2019-01-10 0

GEORGE MICHAEL W

  • Director
10,000 2017-05-15 0

MARKVICKA TAUNIA

  • Director
37,100 2017-05-15 0

PFAFFLE ANTONY CHIEF SCIENTIFIC OFFICER

  • Officer
0 2017-02-07 0

MILBY RANDY CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
403,269 2016-08-10 0

DUFFY MATTHEW

  • Director
28,571 2016-06-03 0

HOUGHTON JOHN C. PRESIDENT, CEO AND ACTING CFO

  • Officer
  • Director
74,139 2014-12-18 0

O'GRADY HARRY CHIEF FINANCIAL OFFICER

  • Officer
0 2014-07-21 0

COHEN RICHARD CFO

  • Officer
0 2014-01-21 0

PHARMABIO DEVELOPMENT INC

  • 10% Owner
778,563 2012-04-12 0

HOFER TIMOTHY M

  • Director
0 2012-01-06 0

LEFKOWITZ JAMES

  • Director
40,272 2011-12-15 0

KLAUSNER MARK A. CHIEF MEDICAL OFFICER

  • Officer
0 2011-03-01 0

HOUSER MARK T. CHIEF MEDICAL OFFICER

  • Officer
52,832 2010-11-26 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KAPLAN MYRON

2020-05-15 P 10,000 $3.85 a 119,734 119,734.00 direct

DILLIONE JANET

2020-05-15 A 5,253 a 5,253 53,473.00 direct

MOUNTS PHOEBE GENERAL COUNSEL

2020-05-11 A 50,000 $5.63 a 50,000 4,675.00 direct

ARMSTRONG JR. JOHN L. EXEC VP OF TECH OPERATIONS

2020-05-11 A 37,500 $4.08 a 37,500 69,378.00 direct

MASSON-HURLBURT ELIZABETH EVP, HEAD OF CLINICAL OPS.

2020-05-11 A 37,500 $5.63 a 37,500 8,000.00 direct

DAVID MATTHEW T EVP, CHIEF FINANCIAL OFFICER

2020-05-11 A 125,000 $4.08 a 125,000 0.00 direct

ARMSTRONG JR. JOHN L. EXEC VP OF TECH OPERATIONS

2020-05-11 A 37,500 $5.63 a 37,500 69,378.00 direct

MOUNTS PHOEBE GENERAL COUNSEL

2020-05-11 A 50,000 $4.08 a 50,000 4,675.00 direct

DAVID MATTHEW T EVP, CHIEF FINANCIAL OFFICER

2020-05-11 A 125,000 $5.63 a 125,000 0.00 direct

MASSON-HURLBURT ELIZABETH EVP, HEAD OF CLINICAL OPS.

2020-05-11 A 37,500 $4.08 a 37,500 8,000.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments